COMBINATION ANTIHYPERTENSION THERAPY: THE “UNDERRESEARCHED” COMBINATIONS

COMBINATION ANTIHYPERTENSION THERAPY: THE “UNDERRESEARCHED” COMBINATIONS

Decrease of blood pressure (BP) and its maintenance on target level is the main factor for cardiovascular mortality and morbidity reduction in hypertensive patients. For effective BP decrease most patients need combination therapy. The article is focused on benefits and adverse events of some combin...

Full description

Saved in:
Bibliographic Details
Published in:Rossiĭskiĭ kardiologicheskiĭ zhurnal no. 5; pp. 132 - 139
Main Authors: Kotovskaya, Yu. V., Runikhina, N. К., Ostapenko, V. S.
Format: Journal Article
Language:English
Published: FIRMA «SILICEA» LLC 01-06-2017
Subjects:
adverse events
arterial hypertension
combination therapy
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Decrease of blood pressure (BP) and its maintenance on target level is the main factor for cardiovascular mortality and morbidity reduction in hypertensive patients. For effective BP decrease most patients need combination therapy. The article is focused on benefits and adverse events of some combinations. In details an issue considered, on the combination of beta-blocker and renin-angiotensine-aldosteron system blocker, which, by the data from Russian observational programs, is the leader among two-component combinations. R
ISSN:1560-4071
2618-7620
DOI:10.15829/1560-4071-2017-5-132-139